DigiCon

What is the approximate percentage of open-angle glaucoma patients whose intraocular pressure (IOP) is uncontrolled, as observed in your practice?

Number of drugs for treatment of open angle glaucoma	Percentage of patients uncontrolled
1 Drug *
2 Drugs *
3 Drugs *

What is the approximate percentage of POAG (primary open-angle glaucoma) patients whom you choose to prescribe Latoprost RT, as observed in your practice? *

A. Less than 10%

B. 11-30%

C. 31-50%

D. >30%

What is your preference for Latoprost RT in patients with open angle glaucoma (OAG), as per your practice? *

A. 1^st add-on

B. 2^nd add-on

C. 3^rd add on

D. Drug initiated as monotherapy

How would you rate your experience with below class of drugs as add-on to Latoprost RT in POAG (primary open-angle glaucoma) (Tick in front of appropriate option):
*

Parameter	Strongly recommended	Recommended	Neutral	Yet to try
ROCK Inhibitor *
Carbonic anhydrase inhibitors (CAI) *
β-Adrenergic receptor blockers *
α-Adrenergic receptor agonists *

In your clinical practice, what is the % Intraocular pressure (IOP) reduction seen with following Prostaglandin Analogues (PGAs) when prescribed to a newly diagnosed Primary open-angle glaucoma (POAG) patient :

Out of 100 patients diagnosed with primary open angle glaucoma, approximately how many patients (in % ) are prescribed Timolol as first line treatment as per your practice? *

A. <10%

B. 10% - 20%

C. 21% -30%

D. 31% -40%

E. 41%-50%

F. >50%

As per observation in your clinical practice, which PGA gives better visual field preservation along with desired IOP control (Kindly tick appropriate option): *

A. Latanoprost

B. Travoprost

C. Bimatoprost

D. All the above

While deciding a treatment strategy for new glaucoma patient, what are the criteria for choosing an anti-glaucoma medication, as per observation in your clinical practice? *

A. IOP-lowering effect

B. Systemic adverse events (AEs)

C. Ocular tolerability

D. Patient Compliance

E. Cost of treatment

F. All the above

As per observation in your clinical practice, which PGA gives better IOP fluctuation control in POAG along with desired IOP control (Kindly tick appropriate option): *

A. Latanoprost

B. Travoprost

C. Bimatoprost

Which is your preferred choice of anti-glaucoma medication in patients with Normal Tension Glaucoma ( NTG ) (Kindly tick appropriate option): *

A. Latanoprost

B. Bimatoprost

C. Travoprost

D. Timolol

E. Brimonidine

F. Netarsudil

G. Ripasudil

H. Brinzolamide

I. Dorzolamide

How would you rate your experience with Latoprost RT in POAG patients in terms of (Tick in front of appropriate option)?

Parameter	Strongly recommended	Recommended	Neutral	Yet to try
Efficacy *
Tolerability *

Which is your preferred Add-on anti-Glaucoma medication, when IOP is not sufficiently controlled on PGA monotherapy *

A. Brimonidine

B. Timolol

C. Brinzolamide

D. Dorzolamide

E. Netarsudil

F. Ripasudil

G. Brimonidine + Timolol

H. Brinzolamide + Brimonidine

Which are the criteria that you consider for considering Latanoprost over Travoprost in POAG patients? *

A. IOP reduction

B. 24-hour IOP control

C. VF preservation

D. Sustained IOP control

E. Higher persistence & adherence

F. Cost

G. Safety

H. All of the above

Which are the criteria that you consider for considering Travoprost over Latanoprost in open angle glaucoma (OAG) patients? *

A. IOP reduction

B. 24-hour IOP control

C. VF preservation

D. Sustained IOP control

E. Higher persistence & adherence

F. Cost

G. Safety

H. All of the above

In which patient age group would you prefer Latanoprost over Travoprost in patients with OAG, as per your clinical practice? *

A. Age 40-60

B. Above 60

C. Both

{{ $ActivityTypeName }}

Research Survey

1 Drug *

2 Drugs *

3 Drugs *